Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

A chimeric vesiculo/alphavirus is an effective alphavirus vaccine.

Chattopadhyay A, Wang E, Seymour R, Weaver SC, Rose JK.

J Virol. 2013 Jan;87(1):395-402. doi: 10.1128/JVI.01860-12. Epub 2012 Oct 17.

2.

Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.

Hallengärd D, Kakoulidou M, Lulla A, Kümmerer BM, Johansson DX, Mutso M, Lulla V, Fazakerley JK, Roques P, Le Grand R, Merits A, Liljeström P.

J Virol. 2014 Mar;88(5):2858-66. doi: 10.1128/JVI.03453-13. Epub 2013 Dec 26.

3.

A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.

García-Arriaza J, Cepeda V, Hallengärd D, Sorzano CÓ, Kümmerer BM, Liljeström P, Esteban M.

J Virol. 2014 Mar;88(6):3527-47. doi: 10.1128/JVI.03418-13. Epub 2014 Jan 8.

4.

Chimeric Chikungunya viruses are nonpathogenic in highly sensitive mouse models but efficiently induce a protective immune response.

Wang E, Kim DY, Weaver SC, Frolov I.

J Virol. 2011 Sep;85(17):9249-52. doi: 10.1128/JVI.00844-11. Epub 2011 Jun 22.

5.

Rhabdovirus-based vaccine platforms against henipaviruses.

Kurup D, Wirblich C, Feldmann H, Marzi A, Schnell MJ.

J Virol. 2015 Jan;89(1):144-54. doi: 10.1128/JVI.02308-14. Epub 2014 Oct 15.

6.

Effective chikungunya virus-like particle vaccine produced in insect cells.

Metz SW, Gardner J, Geertsema C, Le TT, Goh L, Vlak JM, Suhrbier A, Pijlman GP.

PLoS Negl Trop Dis. 2013;7(3):e2124. doi: 10.1371/journal.pntd.0002124. Epub 2013 Mar 14.

7.

Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine.

Partidos CD, Paykel J, Weger J, Borland EM, Powers AM, Seymour R, Weaver SC, Stinchcomb DT, Osorio JE.

Vaccine. 2012 Jun 29;30(31):4638-43. doi: 10.1016/j.vaccine.2012.04.099. Epub 2012 May 11.

8.

Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein.

Kam YW, Lum FM, Teo TH, Lee WW, Simarmata D, Harjanto S, Chua CL, Chan YF, Wee JK, Chow A, Lin RT, Leo YS, Le Grand R, Sam IC, Tong JC, Roques P, Wiesmüller KH, Rénia L, Rötzschke O, Ng LF.

EMBO Mol Med. 2012 Apr;4(4):330-43. doi: 10.1002/emmm.201200213. Epub 2012 Mar 5.

9.

Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits.

Metz SW, Martina BE, van den Doel P, Geertsema C, Osterhaus AD, Vlak JM, Pijlman GP.

Vaccine. 2013 Dec 9;31(51):6092-6. doi: 10.1016/j.vaccine.2013.09.045. Epub 2013 Oct 5.

PMID:
24099875
10.

DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice.

Tretyakova I, Hearn J, Wang E, Weaver S, Pushko P.

J Infect Dis. 2014 Jun 15;209(12):1882-90. doi: 10.1093/infdis/jiu114. Epub 2014 Feb 28.

11.

A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease.

Selvarajah S, Sexton NR, Kahle KM, Fong RH, Mattia KA, Gardner J, Lu K, Liss NM, Salvador B, Tucker DF, Barnes T, Mabila M, Zhou X, Rossini G, Rucker JB, Sanders DA, Suhrbier A, Sambri V, Michault A, Muench MO, Doranz BJ, Simmons G.

PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2423. doi: 10.1371/journal.pntd.0002423. eCollection 2013.

12.

Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus.

Kumar M, Sudeep AB, Arankalle VA.

Vaccine. 2012 Sep 21;30(43):6142-9. doi: 10.1016/j.vaccine.2012.07.072. Epub 2012 Aug 8.

PMID:
22884660
13.

A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.

Brandler S, Ruffié C, Combredet C, Brault JB, Najburg V, Prevost MC, Habel A, Tauber E, Desprès P, Tangy F.

Vaccine. 2013 Aug 12;31(36):3718-25. doi: 10.1016/j.vaccine.2013.05.086. Epub 2013 Jun 4.

PMID:
23742993
14.

Chikungunya virus host range E2 transmembrane deletion mutants induce protective immunity against challenge in C57BL/6J mice.

Piper A, Ribeiro M, Smith KM, Briggs CM, Huitt E, Nanda K, Spears CJ, Quiles M, Cullen J, Thomas ME, Brown DT, Hernandez R.

J Virol. 2013 Jun;87(12):6748-57. doi: 10.1128/JVI.03357-12. Epub 2013 Apr 3.

15.

Chimeric alphavirus vaccine candidates for chikungunya.

Wang E, Volkova E, Adams AP, Forrester N, Xiao SY, Frolov I, Weaver SC.

Vaccine. 2008 Sep 15;26(39):5030-9. doi: 10.1016/j.vaccine.2008.07.054. Epub 2008 Aug 8.

16.

Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus.

Muthumani K, Lankaraman KM, Laddy DJ, Sundaram SG, Chung CW, Sako E, Wu L, Khan A, Sardesai N, Kim JJ, Vijayachari P, Weiner DB.

Vaccine. 2008 Sep 19;26(40):5128-34. doi: 10.1016/j.vaccine.2008.03.060. Epub 2008 Apr 14.

17.

Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose.

Roy CJ, Adams AP, Wang E, Plante K, Gorchakov R, Seymour RL, Vinet-Oliphant H, Weaver SC.

J Infect Dis. 2014 Jun 15;209(12):1891-9. doi: 10.1093/infdis/jiu014. Epub 2014 Jan 7.

18.

Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge.

van den Doel P, Volz A, Roose JM, Sewbalaksing VD, Pijlman GP, van Middelkoop I, Duiverman V, van de Wetering E, Sutter G, Osterhaus AD, Martina BE.

PLoS Negl Trop Dis. 2014 Sep 4;8(9):e3101. doi: 10.1371/journal.pntd.0003101. eCollection 2014 Sep.

19.

Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA Vaccine.

Bao H, Ramanathan AA, Kawalakar O, Sundaram SG, Tingey C, Bian CB, Muruganandam N, Vijayachari P, Sardesai NY, Weiner DB, Ugen KE, Muthumani K.

Viral Immunol. 2013 Feb;26(1):75-83. doi: 10.1089/vim.2012.0061.

20.

Identifying the Role of E2 Domains on Alphavirus Neutralization and Protective Immune Responses.

Weger-Lucarelli J, Aliota MT, Kamlangdee A, Osorio JE.

PLoS Negl Trop Dis. 2015 Oct 16;9(10):e0004163. doi: 10.1371/journal.pntd.0004163. eCollection 2015.

Supplemental Content

Support Center